Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients

BACKGROUND: To identify whether circulating levels of angiogenesis-related factors may be predictive of bevacizumab efficacy in pre-treated metastatic colorectal cancer (mCRC) patients. METHODS: Pre-treatment serum levels of 24 cytokines were measured using a multiplex bead assay (MBA) in 32 pre-tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Abajo, A, Boni, V, Lopez, I, Gonzalez-Huarriz, M, Bitarte, N, Rodriguez, J, Zarate, R, Bandres, E, Garcia-Foncillas, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394977/
https://www.ncbi.nlm.nih.gov/pubmed/22699823
http://dx.doi.org/10.1038/bjc.2012.242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394977/
https://www.ncbi.nlm.nih.gov/pubmed/22699823
http://dx.doi.org/10.1038/bjc.2012.242

Ejemplares similares